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INTRODUCTION
The 11.5 kDa Zn2+-binding protein (ZnBP, parathymosin- a ) is
a reversible inhibitor of phosphofructokinase-1 (Brand and
Söling, 1986; Trompeter et al., 1989). The acidic protein
contains 55% acidic amino acids which are mostly
concentrated in a central acidic cluster conferring the cation
binding and the phosphofructokinase-1 inhibitory activities
(Brand et al., 1988; Trompeter et al, 1989) and is able to bind
to a large variety of cytosolic proteins, including several
glycolytic enzymes when affinity chromatography is
performed with cytosol from rat liver or brain (Brand and
Heinickel, 1991). Although ZnBP is found almost exclusively
in the cytoplasm in liver, brain, adrenal gland, smooth muscle,
kidney, lung, spleen, and testis, it is found mostly in the nuclei
in the intestinal mucosa cells of the crypts of Lieberkühn and
in pancreatic duct cells (Brand et al., 1991). The permanent
cell lines NRK (normal rat kidney cells) and H35 Reuber
hepatoma contain ZnBP exclusively in the nucleus (Trompeter
et al., 1996). As injection of ZnBP into Xenopus oocytes led
to a nuclear uptake of ZnBP (Watts et al., 1990), the motif 
-PKRQKT- in ZnBP was proposed to function as a nuclear
localization signal (NLS). Immunofluorescence studies with
COS-cells overexpressing ZnBP wild type and ZnBP with
mutations of the PKRQKT-motif demonstrated an active
nuclear import of ZnBP (Trompeter et al., 1996). Furthermore,
overexpression of fusion proteins between ZnBP and a
truncated form of calreticulin showed that ZnBP contains a
functionally active bipartite NLS (Trompeter et al., 1996). This
study also demonstrated, that ZnBP can be enriched in the
nucleus by passive diffusion, even when only the N-terminal
half or the central acidic cluster is expressed.
We have previously demonstrated that in freshly isolated rat
hepatocytes ZnBP was located almost exclusively in the
cytoplasm, whereas after 24 hours of culture ZnBP in most
cells had been translocated to the nuclei (Trompeter et al.,
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Although the 11.5 kDa Zn2+-binding protein (ZnBP,
parathymosin- a ) possesses a functional bipartite nuclear
localization signal it was found in most tissues in the
cytoplasm. The cultivation of freshly isolated rat
hepatocytes for 24 hours under standard conditions was
associated with an almost complete translocation of ZnBP
from the cytoplasm to the nuclei. Here we demonstrate,
that this translocation is negatively correlated with cell
density. The translocation of ZnBP to the nucleus can be
inhibited or abolished by inhibitors of protein synthesis
(cycloheximide) or transcription (actinomycin D).
Moreover, cycloheximide can induce a relocation of ZnBP
to the cytoplasm when applied after the appearance of
ZnBP in the nuclei. DMSO, an inhibitor of
dedifferentiation of cultured hepatocytes, abolishes also the
translocation of ZnBP into the nucleus. Thinly seeded cells
keep their ZnBP in the cytoplasm if they are co-cultured
with plasma membranes from Morris MH7777 hepatoma
cells or antibodies against E-cadherin indicating the
involvement of cell adhesion proteins. We have enriched a
protein from the cytosol of fresh hepatocytes which inhibits
the translocation of ZnBP, but not that of albumin-NLS
into the nucleus in a permeabilized cell system. Such an
activity could not be found in the cytoplasm of permanent
cell lines which harbor ZnBP only in the nucleus. A model
for the regulation of the nuclear import of ZnBP is
proposed.
Key words: 11.5 kDa-Zn2+-binding protein, Nuclear transport, Cell
density, Cycloheximide, Cell adhesion protein
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1996). These changes occured independently of changes in the
amount of total ZnBP or of ZnBP m-RNA. We now
demonstrate that the nuclear import of ZnBP in rat hepatocytes
is negatively correlated with cell density and can be blocked
by inhibitors of protein- or mRNA-synthesis.
An effect of cell density on the nuclear import of proteins
has been described previously for the hox 1.3 homeodomain
protein (Odenwald et al., 1987), the nuclear import of
angiogenic factors (Moroianu and Riordan, 1994), the human
metallothionein IIA (Kou et al., 1994), and for the von Hippel-
Lindau tumour suppressor gene product (Lee et al., 1996), but
for none of these proteins data on potential mechanisms
involved were presented. Here, we have not only added a new
example of a protein whose nuclear/cytoplasmic distribution
is affected by cell density, but show for the first time also
results which for the case of ZnBP shed some light on possible
mechanisms involved. A cytoplasmic protein is described
which inhibits nuclear import of ZnBP, but not that of
albumin-NLS. Such an activity could not be isolated from the




Polyclonal antibodies against ZnBP were raised in rabbits according
to standard procedures. The monoclonal antibody DECMA-1 which
recognizes a membrane-proximal part of the extracellular domain of
E-cadherin (Ozawa et al., 1991) was a kind gift from R. Kemler
(Freiburg, FRG). The monoclonal antibody against LI-cadherin as
well as plasma membranes from Morris MH7777 hepatoma cells were
kindly provided by R. Tauber (Berlin, FRG). Importins and and
Ran/TC4 were kind gifts from D. Görlich (Heidelberg, FRG) and H.
Ponstingl (Heidelberg, FRG), respectively. 
Isolation and culture of isolated rat hepatocytes 
Isolation and culture of primary hepatocytes from male Wistar rats
was performed according to the method of Berry et al. (1991a). The
isolated cells were washed twice with sterile modified Krebs-Ringer-
solution (120 mM NaCl, 4.8 mM KCl, 1.2 mM MgSO4, 1.2. mM
KH2PO4, 20 mM Hepes, 0.4% (w/v) BSA, pH 7.4) and separated from
non-parenchymal cells and debris by centrifugation at 50 g for 5
minutes through a Percoll cushion (43.1 ml Percoll, 24.8 ml M199
Earle in 6.5 ml 1.4 M NaCl, 50 mM KCl, 8 mM MgCl2, 4 mM
KH2PO4, 16 mM Na2HPO4, pH 7.4). The pelleted hepatocytes were
resuspended and cultured in M199 Earle supplemented with 100 nM
dexamethasone, 1 nM insulin, 415 IE penicillin/ml, and 150 m g/ml
streptomycin. Cell viability was verified by exclusion of trypan blue.
The cells were diluted to the desired densities, seeded in 24-well 
(14 mm/well) plates on collagen-coated coverslips (Berry et al.,
1991b), and cultured at 37°C. At the indicated times the cells were
fixed with 8% paraformaldehyde, permeabilized with 0.3% (v/v)
Triton X-100 in PBS, and stained for ZnBP using a 1/1000 diluted
polyclonal rabbit anti-rat ZnBP antiserum and a 1/200 diluted FITC-
labeled goat anti-rabbit antiserum. The samples were embedded with
Mowiol 4-88 and analyzed with a Zeiss Axioplan micoscope with a
Zeiss Plan Neofluar 40 · /0.75 objective and a Plan neofluar 100 · /1.30
oil objective equipped with a digitized CCD-camera. Data aquisition
was supported by the KAPPA image base data aquisition software
(Kappa, Gleichen, FRG). Data documentation and analysis was
performed using Adobe Photoshop 4 software. For each experiment
the distribution of ZnBP was evaluated in at least 300 to 400 cells.
All experiments were performed at least twice.
Co-cultivation of isolated rat hepatocytes with plasma
membranes from Morris MH7777 hepatoma cells
Plasma membranes from Morris MH7777 hepatoma cells (equivalent
to 140 m g of protein/well) were seeded together with the hepatocytes
(5 · 104 cells/well) and the nuclear/cytoplasmic distribution of ZnBP
was assessed by immunofluorescence after 3 or 6 hours of cultivation
as given above. 
Modification and overexpression of ZnBP
Wild-type ZnBP was modified by PCR-based addition of a N-terminal
tag containing 7 cysteine residues (see Fig. 1) used for coupling of
the fluorochrome tetramethylrhodamine maleimide. The resulting
PCR-product was subloned into Escherichia coli expression vector
pGEX2T (Pharmacia) using EcoRI sites added to the PCR-primers.
E. coli BL21 cells were transformed with pGEX2T containing the
tagged ZnBP-cDNA. Cells were harvested, resuspended in
homogenizing buffer (50 mM Tris-base, pH 7.4 (4°C), 250 mM
sucrose, 100mM NaCl, 1 mM EDTA) and lysed with lysozyme 
(1 mg/ml culture volume) for 30 minutes on ice. Lysis was completed
by sonication (10 times, 10 seconds at 30% maximal output). The
GST-cys-ZnBP fusion protein was purified from the lysate by GSH-
affinity chromatography. Expression and purity were controlled by
western and immunoblotting.
Fluorochrome labeling of GST-Cys-ZnBP and BSA
GST-cys-ZnBP was labeled with tetramethylrhodamine maleimide
(TMR) after dialysis against 20 mM Hepes, pH 7.4. The reaction was
stopped by addition of a 100-fold excess of reduced glutathione, and
the labeled protein (GST-F-ZnBP) was dialyzed against transport
buffer TB (20 mM Hepes, pH 7.4, 100 mM K-acetate, 5 mM Mg-
acetate, 2 mM DTT, 1 mM EGTA). BSA was labeled with
tetramethylrhodamine isothiocyanate (TRITC). The reaction was
stopped with 1 M NH4Cl, and unbound TRITC removed by gel
filtration over Sephadex G-25 equilibrated with TB. Labeled BSA was
coupled to a peptide (-CYTPPKKKRK) containing the wild-type NLS
of the SV40 large T-antigen by using the bifunctional crosslinker
sulfo-SMCC as given by Moore and Blobel (1992). The fluorescent
protein was designated F-BSA-NLS. 
Permeabilized cell assay
NRK-cells (8 · 104 cells) were seeded on coverslips and cultured for
48 hours at 37°C in MEM/5% FCS. Upon subconfluency, cells were
washed in ice-cold TB and permeabilized for 5 minutes with 80 mg
digitonin/2 ml TB per well as described by Adam et al. (1990). Cells
were washed three times with TB. Endogenous cytosol was removed
by 5 additional washings with TB. The import mix contained in 40 m l
of TB (final concentrations) BSA 10 mM, ATP 1 mM, GTP 0.2 mM,
creatine phosphate 5 mM, creatine kinase 20 U/ml, importin-a 25
m g/ml, importin-b 15 m g/ml, RanTC4 5 m g/ml. Unless otherwise
mentioned, the cells were incubated with the import mix and 1 m g of
F-BSA-NLS or 1 m g GST-F-ZnBP in the dark for 30 minutes at 37°C.
Cells were then fixed for 30 minutes in 9% paraformaldehyde at room
temperature, washed 3 times in TB and embedded with Mowiol 4-88. 
Preparation of rat liver cytosol 
Freshly isolated rat liver tissue (12 g) was cut into small pieces and
homogenized with 2.5 volumes (v/w) of 20 mM Hepes/KOH, pH 7.4,
250 mM sucrose. The homogenate was centrifuged at 1000 g and the
supernatant filtered through cheese-cloth and spun for 10 minutes at
10,000 g. The supernatant was filtered again and spun for 90 minutes
at 100,000 g. The resulting supernatant (‘cytosol’) was dialyzed
against TB, fractionated and stored at - 80°C until used. 
Enrichment of a ZnBP-import inhibiting activity
Rat liver cytosol (6 ml) prepared as given above was concentrated by
Centricon-30 centrifugation to 500 m l and loaded onto a Superdex 200
HiLoad 16/60 column equilibrated with TB. The column was run at
H.-I. Trompeter and others
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0.25 ml/min and 2 ml fractions were collected. Fractions inhibiting
the nuclear import of ZnBP (see Results) were combined and loaded
onto a MonoQ HiLoad 16/10 anion exchange column equilibrated in
buffer A (20 mM Hepes/KOH, pH 7.4). Following washing, bound
proteins were eluted with a linear NaCl gradient from 0 to 1 M in
buffer A at 1 ml/minute. Fractions (2 ml) were pooled as given in Fig.
7B. The pooled fractions were tested for inhibiting the nuclear import
of ZnBP and analyzed by SDS-gel electrophoresis and by non-
denaturing PAA-electrophoresis (Safer, 1998). 
RESULTS
Effects of cell density
Hepatocytes seeded at densities of 5· 104 and 1· 105 cells/well
showed a nuclear localization of ZnBP in most of the cells
already after 2 hours of cultivation (Fig. 2a and b), whereas in
cells seeded at a density of 1.5· 105 cells/well ZnBP remained
in the cytoplasm after 2 hours of cultivation (Fig. 2c). Even after
24 hours of cultivation, ZnBP remained excluded from the
nucleus in cells seeded at a density of 1.5· 105 cells/well (Fig.
2i), whereas at this time point practically all cells grown at the
two lower densities showed a nuclear localization
of ZnBP (Fig. 2g and h). At concentrations below
5· 104 cells/well ZnBP became translocated to
the nucleus within 30 to 60 minutes (results not
shown here). This makes it unlikely that ZnBP at
higher cell concentrations remained in the
cytoplasm as a consequence of high levels of
other proteins competing with ZnBP for nuclear
transport as in this case these competing proteins
would have to be removed or degraded within this
short time interval. 
As many cells exhibited ring-like structures
associated with the nuclei, an accumulation of
ZnBP at the nuclear envelope rather than a
nuclear import had to be excluded. However
examination of cells by confocal laser
microscopy (Fig. 2j,k,l) demonstrated that ZnBP
was indeed localized within the nuclei of most
cells and not at the cytoplasmic side of the
nuclear envelope. In some cells, ring-like
structures were observed even inside the nuclei
(Fig. 2l), demonstrating that imported ZnBP
tends to locate at the inner nuclear membrane.
ZnBP did not seem to be associated with nucleoli
(see e.g. Fig. 2k).
Isolated plasma membranes inhibit
nuclear import of ZnBP
The effect of cell density on the retention of
ZnBP in the cytoplasm pointed to the possibility
that cell-cell interaction might play a role.
Therefore, we co-incubated rat hepatocytes
seeded at 5· 104 cells/well with isolated plasma
membranes (140 m g protein) from Morris
MH7777 hepatoma cells. Morris MH7777
express several unspecific surface proteins (Loch
et al., 1992; Vedel et al., 1983) and high
concentrations of cadherin E (Vestweber and
Kemler, 1985) and cadherin LI (Berndorff et al.,
1994). Co-incubation with the plasma
membranes from MH7777 cells for 3 hours resulted in a
significant inhibition of nuclear import of ZnBP from 76% in
the control cultures to 31% in the cultures co-incubated with
the MH7777 membranes. After 6 hours, only 34% of the cells
co-incubated with MH7777 membranes contained ZnBP in
their nuclei as compared to 86% in control cells (Fig. 3).
Fig. 1. PCR-primer used to generate the N-terminal cys-tag of GST-
cys-ZnBP. A tag of 20 amino acids with 7 cysteine residues was
added to the N terminus of ZnBP by PCR. Cysteine residues and
their codons are printed in bold, the N terminus of wt-ZnBP is
underlined. The EcoRI-site used to clone the PCR-product into
pGEX2T is given in italics.
Fig. 2. Cell density-dependent nuclear import of ZnBP. Rat hepatocytes cultured at
densities of 5· 104 cells/well (a,d,g), 1· 105 cells/well (b,e,h) and 1.5· 105 cells/well
(c,f,i) were analyzed by indirect immunofluorescence for the intracellular distribution
of ZnBP 2 hours (a,b,c), 6 hours (d,e,f), or 24 hours (g,h,i) after seeding. Bar, 100 m m.
(j,k,l) Intranuclear ZnBP as revealed by confocal laser microscopy in cells cultured at
2.5· 104 cells/well for 3 hours (j), at 5· 104 cells/well (k) or 1· 105 cells/well (l) for 24
hours. Bar, 25 m m.
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Antibodies against a cytoplasmic domain of E-
cadherin inhibit nuclear import of ZnBP
In order to inhibit a potential homophilic interaction between
E-cadherins from neighbouring cells we incubated rat
hepatocytes seeded at 1· 105 cells/well with the rat monoclonal
antibody DECMA-1 against E-cadherin (Ozawa et al., 1991).
To our suprise the antibody inhibited nuclear import of ZnBP
under these conditions. Only 15% of the cells showed nuclear
localization of ZnBP as compared to 60% in control cells
incubated without the antibody. Antibodies against LI-cadherin
had no effect on ZnBP localization (results not shown here).
Our results can be explained by antibody induced crosslinking
of E-cadherin and are in line with a recent report of Ozawa and
Kemler (1998) that crosslinking of E-cadherin activates 
E-cadherin-dependent signalling. 
Effects of cycloheximide and actinomycin D
We tested the possibility, that the effect of low cell density is
associated with the increased synthesis of a specific protein
(proteins). If this were so, one would expect an inhibition of
translocation of ZnBP to the nucleus under the condition of
inhibited protein synthesis. To test this hypothesis, rat
hepatocytes were cultured at a density of 5· 104 cells/well for
3 hours in the absence or presence of 1 mM cycloheximide and
at a density of 1 · 105 cells/well for 6 hours in the absence or
presence of 10 m M actinomycin D as given in the methods
section. Under both conditions, 100% of the control cells
contained ZnBP in the nucleus, whereas the translocation of
ZnBP into the nucleus was abolished in almost 100% of the
cells by both compounds (Fig. 4a-d).
We investigated further, whether the inhibition of protein
synthesis at a time point when ZnBP had already been
translocated to the nucleus, could induce a relocation of ZnBP
to the cytoplasm. To this end, rat hepatocytes were cultured at
a density of 1 · 105 cells/well for 6 hours, by which time 86%
of the cells contained ZnBP in the nuclei. The cultivation was
then continued for another 3 hours or 18 hours in the absence
or presence of 1 mM cycloheximide. As given in Table 1,
already after 3 hours, an increased number of cycloheximide
treated cells showed a relocation of ZnBP to the cytoplasm,
and after 18 hours of cycloheximide practically all cells had
their ZnBP translocated back to the cytoplasm whereas control
cells kept ZnBP exclusively in the nuclei. 
DMSO abolishes the translocation of ZnBP to the
nucleus in thinly seeded cells
It is well established that cultured rat hepatocytes start to de-
differentiate relatively soon after start of culture (Padgham et al.,
1993; Villa et al., 1991). We, therefore, considered the possibility
that the state of de-differentiation might affect the localization
of ZnBP in cultured hepatocytes. As DMSO is known to induce
differentiation in various cell lines (Isom et al., 1985; Kost and
Michalopoulos, 1991) and to inhibit de-differentiation of
cultured hepatocytes (Arterburn et al., 1995) we cultured freshly
isolated rat hepatocytes at a density of 1· 105 cells/well in the
presence and absence of 2% (v/v) DMSO. After 6 hours all
control cells had translocated ZnBP to the nucleus (Fig. 4e),
whereas practically all cells cultured in the presence of DMSO
retained ZnBP in the cytoplasm (Fig. 4f). Even after 24 hours
all cells cultured in the presence of DMSO excluded ZnBP from
their nuclei (results not shown here). 
Nuclear import of ZnBP can be specifically inhibited
by a cytoplasmic protein fraction
Next, we tested whether rat liver cytosol contains an activity
able to specifically retain ZnBP in the cytoplasm. From affinity
chromatography experiments, ZnBP is well known to bind to
a large variety of cytosolic proteins, including several
glycolytic enzymes, in vitro (Brand and Heinickel, 1991) and
since several different mechanisms like binding to and
modifying of ZnBP by a cytosolic component might mediate
the cytosolic retention of ZnBP, we directly approached
inhibition of nuclear import of ZnBP mediated by rat liver
cytosol by using the permeabilized cell assay (Adam et al.,
1990). To this end, we analyzed the import of fluorescently
labeled ZnBP in this assay using NRK cells and an import mix
consisting of importin a , importin b , the small GTPase
H.-I. Trompeter and others
Table 1. Cycloheximide (CHX) initiates transport of ZnBP




Control, 6 hours 14 86
Control, 9 hours 11 89
CHX, 9 hours 71 29
Control, 24 hours 1 99
CHX, 24 hours 99 1
Hepatocytes were seeded at a density of 5 · 104 cells/well and cultured for 6
hours. Then cycloheximide at a final concentration of 1 mM was added and
the cultivation continued for another 3 hours (CHX, 9 hours) or 18 hours
(CHX, 24 hours). Control cells were incubated for the same times without
cycloheximide. At the given time points the cells were fixed and analyzed for
the distribution of ZnBP as given in Materials and Methods. For each
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Ran/TC4, and an ATP regenerating system. The fluorochrome
tetramethylrhodamine maleimide was linked to a Cys-tag
located N-terminally of the ZnBP in a recombinant GST-ZnBP
fusion protein (GST-F-ZnBP). Tetramethylrhodamine
isothiocyanate labeled BSA linked to the SV40 large T-antigen
NLS (F-BSA-NLS) served as control protein. Both substrates,
GST-F-ZnBP as well as F-BSA-NLS were imported into the
nucleus of permeabilized NRK-cells only in the presence of
the afore mentioned import factors (Fig. 5). This demonstrates
that nuclear import of both substrates involves the recognition
of their NLS sequences. Since rat liver cells in situ contain
ZnBP almost exclusively in the cytoplasm (Brand et al., 1991),
the putative protein inhibiting the nuclear import of ZnBP
should exist at least in small amounts in rat liver cytosol. To
test this we analyzed whether increasing amounts of GST-F-
ZnBP were able to titrate out such a protein. In these
experiments, dialyzed rat liver cytosol (20 m g protein/assay)
was added to the import assay. As shown in Fig. 6 the uptake
of F-BSA-NLS occured in 100% of the cells independently of
the concentration of F-BSA-NLS. In the case of GST-F-ZnBP,
however, 25% and 15% of the cells excluded the fusion protein
from their nuclei at a concentration of 100 ng/assay and 
300 ng/assay, respectively. At 500 ng/assay almost 100% of the
cells showed a nuclear uptake of GST-F-
ZnBP, but considerable amounts of the
fusion protein remained in the cytoplasm.
At 1000 ng/assay, all cells exhibited a
clear nuclear uptake, although some
fusion protein remained in the cytoplasm. 
In contrast, when using cytosols from
HeLa-, NRK-, or Reuber H35 hepatoma
cells no inhibition of the nuclear import
of GST-F-ZnBP was detected at any
substrate concentration (data not shown). 
These findings demonstrate that small
amounts of a free import inhibiting
protein are present in the cytosol of fresh
hepatocytes despite the endogenous
cytosolic ZnBP, whereas no such activity
seems to exist in the cytosol of
permanent cell lines which is in line with
our observation that these cells contain
ZnBP almost exclusively in the nucleus.
To substantiate the existence of
an inhibitory protein further, we
fractionated rat liver cytosol on a
Superdex 200 HiLoad 16/60 gel
filtration column and tested the fractions in the protein import
assay. Proteins (5 m g/assay) from fractions 2 and 3 of the
elution profile (Fig. 7A), corresponding to a molecular mass
>250 kDa led to a cytoplasmic retention of GST-F-ZnBP in
38% to 51% of the analyzed cells (see example in Fig. 8), while
5 m g protein from pool 4 was still able to retain GST-F-ZnBP
in the cytoplasm of 5-8% of the inspected cells. Proteins from
fractions 5-16 had no effect on the nuclear import of GST-F-
ZnBP. None of the tested fractions was able to inhibit the
nuclear import of F-BSA-NLS (Fig. 8). 
In another Superdex 200 gel filtration experiment, in which
5 m g protein of the peak fraction inhibited nuclear import of
GST-F-ZnBP in 51% of the cells, the active fraction was
purified further by MonoQ HiLoad 16/60 anion exchange
chromatography. The most active fraction eluted at 400-
415 mM NaCl (Fraction 9 in Fig. 7B). It inhibited at 5 m g
protein/assay the nuclear import of GST-F-ZnBP in 100% of
the inspected cells (Fig. 9) without inhibiting the nuclear
import of the F-BSA-NLS (Fig. 9). Proteins from the
neighboring fractions 8 and 10 did not have an inhibitory effect
on the nuclear import of GST-F-ZnBP (Fig. 9). Fraction 9
showed one main protein band during native gel
electrophoresis (Fig. 10) but spread up into several bands when
Fig. 4. Effect of inhibition of protein
synthesis and of DMSO on the
nuclear/cytoplasmic distribution of ZnBP. (a-
d) Freshly prepared rat hepatocytes were
cultured for 3 hours (a and b) or 6 hours (c
and d) in the absence (a and c) or presence of
1 mM cycloheximide (5· 104 cells/well, b) or
of 10 m M actinomycin D (1· 105 cells/well,
(d) and analyzed for the localization of
ZnBP. (e and f) Freshly prepared rat
hepatocytes (5· 104 cells/well) were cultured
for 6 hours in the absence (e) or presence (f)
of 2% (v/v) DMSO and analyzed for the
localization of ZnBP. Bar, 100 m m.
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separated by SDS-PAGE (data not shown here). Proteins from
fraction 9 lost their inhibitory action on nuclear import of GST-
F-ZnBP after heat inactivation, indicating the proteinaceous
nature of this activity (data not shown). The nuclear import of
fluorescently labeled cys-ZnBP generated from GST-cys-ZnBP
by thrombin cleavage was also inhibited by proteins from
fraction 9 (results not shown here), indicating that protein B
does not inhibit the nuclear import of ZnBP by an unspecific
interaction with GST. 
DISCUSSION
Our previous studies had revealed a cytoplasmic localization
of ZnBP in most mammalian tissues including hepatocytes
(Brand et al., 1991). Isolated hepatocytes preserved this
distribution only when they were cultured at high density as
shown by conventional immunofluorescence and by confocal
laser microscopy. Confocal laser miscroscopy showed clearly
that ‘nuclear’ ZnBP which sometimes appeared in ring-like
structures during conventional immunofluorescence
microscopy was localized within the nuclei. In addition,
confocal laser microscopy revealed occasionally ring-like
structures inside the nuclei (Fig. 2j-l), which may possibly
reflect preferential binding of ZnBP to structures located near
the nucleoplasmic side of the nuclear envelope. Binding of
ZnBP to intranuclear structures has been proposed earlier
(Trompeter et al., 1996). The cytoplasmic distribution of ZnBP
in most tissues and in densely seeded hepatocytes occurs
inspite of the fact that the protein contains a functionally active
bipartite NLS (Trompeter et al., 1996). This raises the
following questions: (1) how is the NLS of ZnBP inactivated
so that ZnBP is retained in the cytoplasm? (2) which regulatory
mechanisms determine the cytoplasmic/nuclear distribution of
ZnBP? (3) how can cell density interfere with these regulatory
mechanisms? The fact that the cytoplasmic retention of ZnBP
in isolated cultured rat hepatocytes depends on cell density
indicates that cell-cell contact may play an important role. 
One possibility would be a dramatic increase in the amount
of other proteins with an NLS which could compete for binding
to the importins or other steps of the importin-dependent
nuclear import. The latter possibility seems unlikely for the
case of ZnBP for the following reasons: (1) at low cell density
translocation of ZnBP into the nucleus can occur within 30-60
H.-I. Trompeter and others
Fig. 5. Nuclear import of fluorochrome-labeled GST-ZnBP fusion
protein in permeabilized NRK cells depends on the presence of the
nuclear import factors importin a , importin b and RanGTP. Nuclear
import of GST-F-ZnBP (a and c) and F-BSA-NLS (b and d) was
tested in the absence (a and b) and presence (c and d) of the import
factors. Arrows indicate GST-F-ZnBP or F-BSA-NLS accumulated
in the cytoplasm.
Fig. 6. Inhibition of nuclear import of GST-F-ZnBP by rat liver
cytosol is overcome by increasing concentrations of GST-F-ZnBP.
Increasing amounts (100-1000 ng) of GST-F-ZnBP (left panels) or 
F-BSA-NLS (right panels) were added to the permeabilized cell
assay in the presence of rat liver cytosol (corresponding to 20 m g
protein/assay) and nuclear import factors and checked for nuclear
import. At 100 ng GST-F-ZnBP nuclear import could not be
observed in 25% of the cells (see arrows), whereas all cells showed
nuclear import of F-BSA-NLS at the same concentration. At 300 ng
GST-F-ZnBP still 15% of the cells showed little or no nuclear
uptake, whereas at 500 and 1000 ng/ assay of GST-F-ZnBP all cells
showed nuclear uptake, but even then GST-F-ZnBP could still be
observed in the cytoplasm. 
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minutes which could only be explained by assuming that the
competing proteins were removed and/or degraded during this
short interval; (2) we have shown recently (Trompeter et al.,
1996) that due to its small size ZnBP can be translocated to the
nucleus also by diffusion i.e. in an NLS-independent way,
although less effectively. Hence, the existence of competing
NLS-proteins should not block completely the appearance of
ZnBP in the nucleus. In addition, putative postranslational
modifications of ZnBP changing its secondary structure and
thereby masking the NLS would also not inhibit nuclear import
by passive diffusion. 
A protein with a functional NLS could also be retained in
the cytoplasm by binding to a cytoplasmic protein(s) which
itself is unable to reach the nucleus. We used the permeabilized
cell assay (Adam et al., 1990) to determine whether cytosol
from rat liver contains an activity able to inhibit the active
nuclear import of ZnBP. Freshly prepared rat liver cytosol was
indeed able to inhibit the nuclear import in a small percentage
of cells at small but not at higher concentrations of GST-F-
ZnBP without having any effect on the nuclear import of F-
BSA-NLS at similar concentrations. By gel filtration and anion
exchange chromatography this activity could be enriched from
fresh rat liver cytosol. It had an apparent molecular
mass >250 kDa and was heat-labile. It did not inhibit
nuclear import of F-BSA-NLS under identical
experimental conditions, pointing to its specificity for
ZnBP. The most enriched protein fraction blocked
nuclear import of GST-F-ZnBP in 100% of the cells
at a concentration of 5 m g/assay and appeared as one
main band with a molecular mass >250 kDa during
native electrophoresis, but as several protein bands
with molecular masses >50 kDa during SDS-PAGE.
Thus this import inhibiting protein may be a hetero-
oligomer. Since the import of GST-F-ZnBP and F-
BSA-NLS required only importins, the small GTPase
Ran TC4, and an energy-regenerating system it seems
likely that import inhibiting protein inhibits the
nuclear import of ZnBP by interfering with the
recognition of the NLS of ZnBP by importins. No
protein inhibiting nuclear import of ZnBP could be
isolated from the cytosol of permanent cell lines
(HeLa, NRK, Reuber hepatoma cells) in accordance
with the fact that in these cells ZnBP was always
observed in the nucleus independently of cell density.
This supports our conclusion, that the retention of
ZnBP in the cytosol of freshly isolated or densely
seeded rat hepatocytes is accomplished by a
cytoplasmic proteinacous factor (factors). 
How might this fraction achieve the cytosolic
retention of ZnBP? Theoretically, the cytosolic factor
could possess a proteolytic activity specific for ZnBP
thus diminishing nuclear uptake of ZnBP just by
destroying ZnBP in the cytosol. This seems unlikely
for the following reasons: (a) the inhibitory factor
was enriched from cytosol freshly prepared from the
livers of fed rats which contain all their endogenous
ZnBP in the cytoplasm; (b) the shift in the
nuclear/cytoplasmic distribution of ZnBP in isolated
hepatocytes is not accompanied by a loss of ZnBP
(Trompeter et al., 1996); (c) inhibition of translocation
of ZnBP by cycloheximide, actinomycin or DMSO in
thinly seeded hepatocytes is not accompanied by a loss of
ZnBP in the cytoplasm but rather by an accumulation (Fig. 4). 
We propose that we have enriched a protein (proteins) which
binds to ZnBP and thereby (1) masks and inactivates the NLS
of ZnBP and (2) increases the molecular weight of the complex
to prevent it from passive diffusion into the cytoplasm. It
appears that the inhibition of nuclear ZnBP-uptake is specific
as the translocation of F-BSA-NLS was not inhibited. F-BSA-
NLS contains in contrast to GST-F-ZnBP more than one NLS.
Therefore, a cytoplasmic factor interacting directly with the
NLS could be less effective in the case of F-BSA-NLS.
However, the following observations make this less likely: (a)
under conditions were the enriched cytoplasmic fraction
blocked nuclear uptake of GST-F-ZnBP in 100% of the cells,
in none of the cells nuclear uptake of F-BSA-NLS was
inhibited; (b) if F-BSA-NLS would bind via its NLS to the
cytoplasmic factor, it should compete with GST-F-ZnBP for
this factor at low concentrations of cytosol or of the enriched
factor, i.e. F-BSA-NLS should under these conditions enhance
nuclear uptake of GST-F-ZnBP. This was not the case (results
not shown here). It seems unlikely that the enriched protein is
phosphofructokinase-1, as this should appear during in SDS-
Fig. 7. Elution profiles of the inhibitory protein activity during gel filtration of
rat liver cytosol over Superdex 200 HiLoad (a) and subsequent anion exchange
chromatography on MonoQ HiLoad (b). Shaded fractions (fractions 2 and 3 in
a and fraction 9 in b) showed the highest inhibition of nuclear import of GST-F-
ZnBP (see Figs 8 and 9). The activity elutes from the Superdex 200 with an
app. molecular mass of >250 kDa. 
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PAGE as a uniform protein band of about 80 kDa. In this
context one should also realize that the binding of ZnBP to
PFK-1 is not very specific (Brand and Heinickel, 1991) and
may just indicate the ability of ZnBP to react relatively easily
with other proteins. An elucidation of the precise mechanism
of ZnBP-retention will only be possible after final purification
of the cytoplasmic factor(s) and functional assays with the
recombinant protein(s).
An inhibition of recognition of the NLS of ZnBP by a
cytosolic protein resembles the masking of the NLS of the
transcription factor NF-k B (Baeuerle, 1991) by I-k B in the
cytoplasm. This concept requires that in sparsely seeded
hepatocytes, where ZnBP is translocated to the nuclei, the NLS
of ZnBP is no longer masked. This could result either from a
lack of the cytosolic protein or from its temporary inactivation.
As inhibition of protein synthesis by cycloheximide after
translocation of ZnBP into the nucleus in thinly seeded cells
leads to a reappearence of ZnBP in the cytoplasm, it seems
unlikely that a lack of the import-inhibiting protein due to
degradation is responsible for the nuclear import of ZnBP into
the nucleus of thinly seeded cells. It is much more likely that
in thinly seeded cells, this protein has only lost its (putative)
capability to block the interaction between ZnBP and the
importins. The cycloheximide experiments indicate (1) that the
inactivation of the import-inhibiting protein is reversible, and
(2) that its conversion from an active to an inactive state (e.g.
by phosphorylation/dephosphorylation) might be catalyzed by
H.-I. Trompeter and others
Fig. 8. Inhibition of nuclear import of GST-F-ZnBP, but not of 
F-BSA-NLS by fractions from Superdex 200 gel filtration of rat liver
cytosol. Aliquots corresponding to 5 m g of protein from the fractions
of the Superdex 200 gel filtration of rat liver cytosol (see Fig. 7a)
were added to permeabilized NRK-cells and nuclear import of GST-
F-ZnBP and F-BSA-NLS was examined in the presence of import
factors as given in the methods section. None of the fractions
inhibited nuclear import of F-BSA-NLS, whereas proteins from
fraction 1 abolished or inhibited nuclear import of GST-F-ZnBP in
5%, from fraction 2 in 34%, from fraction 3 in 38%, and from
fraction 4 in 8% of the cells. No inhibition was obtained with
proteins from fraction 5 or later fractions. Arrows mark cells with
cytoplasmic GST-F-ZnBP.
Fig. 9. Inhibition of nuclear import of GST-F-ZnBP by a fraction
from rat liver cytosol enriched by MonoQ HiLoad anion exchange
chromatography. Fractions 2 and 3 obtained by Superdex 200 gel
chromatography were pooled, loaded onto a MonoQ Hiload 16/10
anion exchange column, and eluted with a NaCl-gradient as indicated
in Fig. 7B. Aliquots from the collected fractions corresponding to 5
m g of protein were added to the import assay as in Fig. 8. None of the
fractions inhibited the nuclear translocation of F-BSA-NLS, whereas
fraction 9 abolished nuclear uptake of GST-F-ZnBP in 100% of the
cells. Aliquots from fractions 8 or 10 were almost without effect. The
arrows indicate GST-F-ZnBP accumulating in the cytoplasm. 
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a regulatory protein R. Protein R must have a high turnover
and, therefore, its amount has to be strongly sensitive to
inhibition of protein synthesis. In thinly seeded cells the
activity of protein R would be relatively high, in densely
seeded cells low. This may be an oversimplification as protein
R may not act directly on the import inhibiting protein but via
additional factors, but this would not change the basic concept.
Under condition of inhibited protein synthesis, ZnBP
returns to the cytoplasm, which demonstrates that the import
inhibiting protein must have regained its activity. The
proposed high-turnover protein R can under these conditions
not be responsible for this reactivation and other mechanism
have to be taken into account. If the import inhibiting protein
turns out to be a complex of several polypeptides, it might
contain an endogenous activity keeping it in its active state.
Also, an additional protein might ensure the active state of the
import inhibiting protein. In both cases, the intracellular
localization of ZnBP would be dependent on the relative
activities of R and its counterpart. If the activity of R
dominates, the import inhibiting protein would become
inactive and allow ZnBP to be imported. If R is not present or
inactive, the import inhibiting protein would become active
and keep ZnBP in the cytoplasm.
How can this hypothetical type of regulation be linked to the
recognition of cell density? We have shown here, that thinly
seeded hepatocytes retain ZnBP in the cytoplasm when
cultured in the presence of plasma membranes from Morris
MH7777 hepatoma cells, which are known to be rich in
cadherins. This indicates that cell/cell interaction can affect the
nuclear/cytoplasmic distribution of ZnBP. The import
inhibiting protein is a cytoplasmic protein and, therefore, the
hypothetical protein R supposed to catalyze directly or
indirectly its reversible inactivation, most likely exists also in
the cytoplasm. It could also be that protein R is reversibly
associated with the plasma membrane. Such an association
could then affect its turnover. However, more likely additional
factors are involved which transmit cell density signals from
the plasma membrane to components regulating the turnover
of protein R. 
Surprisingly, the monoclonal antibody DECMA-1 directed
against the extracellular domain of E-cadherin inhibited the
nuclear translocation of ZnBP in rat hepatocytes. As cadherin
E-mediated signalling requires dimerized E-cadherins (Ozawa
and Kemler, 1998), it seems possible, that the antibodies
induced a cross-linking of E-cadherins. This may have led to
similar intracellular responses as homophilic interactions of 
E-cadherins from neighbouring cells. Nevertheless, this
experiment shows the participation of E-cadherin in regulating
the intracellular distribution of ZnBP.
Isolated rat hepatocytes in culture show all signs of rapid de-
differentiation together with the translocation of ZnBP into the
nucleus. But this relationship is more than circumstantial as
indicated by the fact that DMSO not only inhibits de-
differentiation of hepatocytes (Ai et al., 1995; Kuliczkowski et
al., 1995; Otsuka-Murakami and Nishimoto, 1995), but also
abolishes completely over a long time the translocation of
ZnBP from the cytoplasm to the nucleus. It should also be
noted, that the amount of ZnBP in human breast cancer is
dramatically increased (Tsitsiloni et al., 1998), an observation
we could confirm for hepatocarcinoma cells (unpublished
results). In contrast, benign breast tumors did not show
increased ZnBP expression (Tsitsiloni et al., 1998). Although
these observations point to a putative role of ZnBP in the
regulation of de-differentiation and/or proliferation, its precise
function still remains to be elucidated as well as the detailed
mechanism that regulates its nuclear import in a cell-density
dependent manner. It still remains unclear, whether ZnBP
fullfills its function in the cytoplasm, in the nucleus or in
both compartments and whether the in-vitro binding to
several cytosolic proteins (Brand and Heinickel, 1991) is of
physiological relevance. It has been shown recently (Kondili et
al., 1996) that ZnBP can bind to histone H1. In view of the fact
that ZnBP is an extremely acidic protein and that histone H1
under identical conditions binds also to poly (glutamate) the
specificity of this interaction and its physiological occurrence
and function need to be proved. In speculating about a
physiological role of ZnBP in the nucleus one should keep in
mind that ZnBP shares similarities with prothymosin-a , a
nuclear protein of similar size and acidity also possessing an
active NLS. The expression of prothymosin-a is under the
control of c-myc (Lutz et al., 1996; Ben-Yosef at al., 1998). It
modulates the interaction of histone H1 with chromatin
(Karetsou et al., 1998; Gomez-Marquez and Rodriguez, 1998),
and overexpression of the protein accelerates proliferation and
retards differentiation in HL-60 cells (Rodriguez et al., 1998).
It has also been reported that prothymosin- a stimulates the
phosphorylation of EF-2 and thus could also affect reactions
in the cytosol (Vega et al., 1998). Unfortunately, a systematic
analysis of the cytoplasmic/nuclear distribution of
prothymosin-a in normal mammalian tissue cells is lacking.
Iguchi et al. (1998) have observed that high concentrations of
Zn2+ induce necrosis in LNCaP- and in PC-3 cells. This effect
was accompanied by an increased expression of ZnBP but also
of other small proteins including metallothionein. As we could
not observe an increased level of ZnBP and ZnBP-m-RNA in
hepatocytes under conditions where ZnBP became translocated
to the nucleus (Trompeter et al., 1996), we consider it unlikely
that the Zn2+-induced effects described by Iguchi et al. (1998)
can be related to the cell density-induced changes in the
nuclear/cytoplamic distribution of ZnBP. 
Fig. 10. Analysis of the enriched
inhibitory protein(s) by native PAA-gel
electrophoresis. Rat liver cytosol was
fractionated by Q-Sepharose anion
exchange chromatography and tested
for inhibitory activity. Fractions
containing inhibitory activity were
combined and further fractionated by
anion exchange chromatography via
Mono-Q-HiLoad. Fractions with
inhibitory activity were subsequently
separated further by size exclusion
chromatography via Superdex S-200.
The fraction containing proteins of
>250 kDa was concentrated by
Centricon 30 centrifugation. Protein 
(5 m g) from this fraction inhibited
nuclear uptake of ZnBP in 100% of
analyzed cells (not shown here). The
enriched protein (5 m g) was processed
by native PAA-electrophoresis and
stained with Coomassie Blue. Lane 1: molecular mass markers; 
lane 2: inhibitory protein. 
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